Osteoimmunology (advances In Experimental Medicine And Biology)
by Yongwon Choi /
2007 / English / PDF
2.6 MB Download
A Key Regulator of Postnatal Skeletal Remodeling.- Ectodomain
Shedding of Receptor Activator of NF-KB Ligand.- The Negative
Role Of Ids In Osteoclastogenesis.- Functional Genetic and
Genomic Analysis of Modeled Arthritis.- Dexamethsone Suppresses
Bone Formation via the Osteoclast.- Immunologic Regulation Of
Bone Development.- Pth Regulates The Hematopoietic Stem Cell
Niche In Bone.- Regulation Of Hematopoietic Stem Cells In The
Osteoblastic Niche.- The Chemokine Cxcl12 And Regulation Of Hsc
And Lymphocyte Development In The Bone Marrow Niche.- Osteoclast
Precursor Cells.- Interaction with estrogen receptors as
treatment of arthritis and osteoporosis.- Novel Signaling
Pathways And Therapeutic Targets In Osteoclasts.- The Enigmatic
Function of TREM-2 in Osteoclastogenesis.- Role of cell-matrix
interactions in osteoclast differentiation.- Positive and
negative roles of IL-6, STAT3 and SOCS3 in inflammatory
arthritis.- Control of Osteoclast activity and bone loss by IKK
subunits: new targets for therapy.- Targeting Osteoporosis And
Rheumatoid Arthritis By Active Vaccination Against Rankl.- RANKL
Inhibition: From Mice to Men (and Women).
A Key Regulator of Postnatal Skeletal Remodeling.- Ectodomain
Shedding of Receptor Activator of NF-KB Ligand.- The Negative
Role Of Ids In Osteoclastogenesis.- Functional Genetic and
Genomic Analysis of Modeled Arthritis.- Dexamethsone Suppresses
Bone Formation via the Osteoclast.- Immunologic Regulation Of
Bone Development.- Pth Regulates The Hematopoietic Stem Cell
Niche In Bone.- Regulation Of Hematopoietic Stem Cells In The
Osteoblastic Niche.- The Chemokine Cxcl12 And Regulation Of Hsc
And Lymphocyte Development In The Bone Marrow Niche.- Osteoclast
Precursor Cells.- Interaction with estrogen receptors as
treatment of arthritis and osteoporosis.- Novel Signaling
Pathways And Therapeutic Targets In Osteoclasts.- The Enigmatic
Function of TREM-2 in Osteoclastogenesis.- Role of cell-matrix
interactions in osteoclast differentiation.- Positive and
negative roles of IL-6, STAT3 and SOCS3 in inflammatory
arthritis.- Control of Osteoclast activity and bone loss by IKK
subunits: new targets for therapy.- Targeting Osteoporosis And
Rheumatoid Arthritis By Active Vaccination Against Rankl.- RANKL
Inhibition: From Mice to Men (and Women).
